1. Home
  2. VRDN vs BHE Comparison

VRDN vs BHE Comparison

Compare VRDN & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • BHE
  • Stock Information
  • Founded
  • VRDN 2006
  • BHE 1979
  • Country
  • VRDN United States
  • BHE United States
  • Employees
  • VRDN N/A
  • BHE N/A
  • Industry
  • VRDN Medical Specialities
  • BHE Electrical Products
  • Sector
  • VRDN Health Care
  • BHE Technology
  • Exchange
  • VRDN Nasdaq
  • BHE Nasdaq
  • Market Cap
  • VRDN 1.5B
  • BHE 1.7B
  • IPO Year
  • VRDN N/A
  • BHE 1990
  • Fundamental
  • Price
  • VRDN $20.14
  • BHE $47.06
  • Analyst Decision
  • VRDN Strong Buy
  • BHE Strong Buy
  • Analyst Count
  • VRDN 10
  • BHE 3
  • Target Price
  • VRDN $37.25
  • BHE $42.33
  • AVG Volume (30 Days)
  • VRDN 1.1M
  • BHE 272.0K
  • Earning Date
  • VRDN 11-12-2024
  • BHE 10-30-2024
  • Dividend Yield
  • VRDN N/A
  • BHE 1.45%
  • EPS Growth
  • VRDN N/A
  • BHE N/A
  • EPS
  • VRDN N/A
  • BHE 1.72
  • Revenue
  • VRDN $302,000.00
  • BHE $2,690,572,000.00
  • Revenue This Year
  • VRDN N/A
  • BHE N/A
  • Revenue Next Year
  • VRDN N/A
  • BHE $4.51
  • P/E Ratio
  • VRDN N/A
  • BHE $27.37
  • Revenue Growth
  • VRDN N/A
  • BHE N/A
  • 52 Week Low
  • VRDN $11.40
  • BHE $24.75
  • 52 Week High
  • VRDN $27.20
  • BHE $52.57
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 36.38
  • BHE 51.59
  • Support Level
  • VRDN $22.40
  • BHE $50.81
  • Resistance Level
  • VRDN $27.20
  • BHE $52.57
  • Average True Range (ATR)
  • VRDN 1.36
  • BHE 1.75
  • MACD
  • VRDN -0.41
  • BHE -0.04
  • Stochastic Oscillator
  • VRDN 6.37
  • BHE 45.61

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and advanced manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.

Share on Social Networks: